Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 31 results for "zenotech"

Zenotech Labs to be referred to BIFR
Business Standard

Zenotech Labs to be referred to BIFR

Sun Pharma, Daiichi Sankyo together hold 66.85% shares of the company BS Reporter May 26, 2015 Last Updated at 20:30 IST The board of directors of Hyderabad-based Zenotech Laboratories Limited, which is now in the hands of Sun Pharmaceutical Industries ... Business Standard, 1 day ago

1 images for "zenotech"

Business Standard, 1 day ago

Zenotech Laboratories reports standalone net loss of Rs 10.20 crore in the March 2015 quarter

Sales rise 67.92% to Rs 0.89 crore Net Loss of Zenotech Laboratories reported to Rs 10.20 crore in the quarter ended March 2015 as against net loss of Rs 2.61 crore during the previous quarter ended March 2014. Sales rose 67.92% to Rs 0.89 crore in the ...
 Business Standard1 day ago

Zenotech rises to upper limit on Sun Pharma's open offer

Zenotech Laboratories touched its 52-week high in trade today, with the scrip hitting an upper circuit limit of 5 per cent in a reaction to Sun Pharmaceutical Industries' open offer to acquire nearly 9.7 mn shares in the company at Rs 20.87 per share. A ...
 Economic Times1 month ago Zenotech hits upper circuit on Sun's open offer  Economic Times1 month ago
India Infoline

Zenotech Laboratories stock ends 5% upper limit

Zenotech Laboratories was locked at the 5% upper limit at Rs. 45.25 after Sun Pharma made an open offer to buy 9.7 million shares at Rs. 20.87 pursuant to the Ranbaxy merger deal. Zenotech Laboratories was locked at the 5% upper limit at Rs. 45.25 after Sun ...
 India Infoline1 month ago
Primeur Magazine

Welsh students recognised for smashing 1,000 mph Supersonic Cymru challenge using supercomputing skills

Bangor - Over 200 children were recognised for their hard work in the Supersonic Cymru Challenge Awards at Swansea University. Led by High Performance Computing (HPC) Wales, the innovative competition was inspired by the Bloodhound SSC project and ...
 Primeur Magazine1 day ago

Daily Market Strategy - Flat start; swings in store

Just celebrate the life you had, not the life you could've had - Magic Johnson As the NDA government led by BJP's Narendra Modi completes one year in office, most CEOs acknowledge the reforms undertaken and initiatives done to reduce corruption ...
 India Infoline2 days ago

Pharma Leader Series: Top 25 Biosimilar Drug Manufacturers 2015-2025

/PRNewswire/ -- Biosimilar drug producers - your guide to those companies' activities and prospects What does the future hold for makers of biosimilar medicines? Discover those companies' outlooks from 2015. You see results, trends, opportunities ...
 TickerTech.com1 month ago

Patent Expiration to Propel the Global Biosimilar and Follow-on Biologics Market During the Forecast Period

Transparency Market Research Report Added "Biosimilar and Follow-On Biologics Market" to its database. Albany, NY -- (ReleaseWire) -- 03/24/2015 -- One of the main factors driving the global biosimilar and follow-on biologics market is patent ...
 Digital Journal2 months ago

National Science Week sees ultimate science project open to pupils in Wales

This week, over 200 pupils from selected schools in Wales have begun competing on Supersonic Cymru, an innovative challenge for key stage 3 pupils to break the World Land Speed Record using high performance computing. Led by High Performance ...
 Noodls2 months ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less